Holy Basil
In short
Summary of findings for quick reference
Holy Basil (Ocimum tenuiflorum, Tulsi) is a sacred and medicinal plant of India, classified in Ayurveda as a rasayana, a rejuvenative herb for resilience and well-being. The classical Charaka Samhita places it among the aromatic, respiratory and resilience herbs, and it is documented in parallel in the Siddha system. Above all it is a living household tradition: a Tulsi plant is grown in courtyards and home shrines and tended daily, and the leaf is taken as a tea for coughs, colds and general strength. That tradition is deep and continuous, but regionally focused. It is a South Asian story, not a herb of Greco-Roman or central European antiquity, which is why this entry sits at established historical significance rather than the top tier.
The standing references for the leaf are the Ayurvedic Pharmacopoeia of India, which lists Tulasi leaf and seed for rhinitis, cough and influenza, the World Health Organization leaf monograph (Folium Ocimi Sancti), and a Health Canada leaf monograph for traditional expectorant and demulcent use. There is no European Medicines Agency HMPC monograph for Holy Basil and no permitted EFSA health claim. The modern word adaptogen, which is often applied to Tulsi, is a descriptive term from Soviet-era Russian research, not a regulated medical category, and it points at the same plant Ayurveda already calls a rasayana.
Modern clinical work is early and small. Saxena and colleagues reported reductions on standardized stress scales over six weeks in 2012, and the Jamshidi and Cohen systematic review of 2017 summarized the human trials across stress, metabolic and immune outcomes as mostly small and methodologically mixed, with promising but not conclusive signals. The picture is best read as a deep traditional rasayana with an early and limited evidence base, not a clinical treatment. The eugenol in the leaf oil warrants caution with anticoagulants, animal studies report a blood sugar lowering effect so people on diabetes medication should monitor, and Ayurvedic tradition advises caution in pregnancy. Holy Basil is not the same as culinary Sweet Basil (Ocimum basilicum).
Clinical evidence ↔ Historical significanceWe display two separate evidence categories: clinical evidence from modern trials and historical significance from documented healing tradition. Both are valuable, but they answer different questions.Read more
In every encyclopedia entry we evaluate two distinct categories of evidence. Clinical evidence as used in trials meets a narrower but scientifically essential bar. At the same time, the hundreds of thousands of plant species worldwide have only partially been captured and tested in modern studies.
Alongside the trial picture our researchers compile a comprehensive overview of where and since when a plant has been used across different traditions of natural medicine. When a plant has been used as a medicinal plant in many cultures across many generations, that historical significance deserves to be visible too.
Our position: a truly informative overview emerges only when both categories sit side by side. We communicate transparently what counts as what.
Overview
Holy Basil (Ocimum tenuiflorum, synonym Ocimum sanctum), known in Sanskrit and across India as Tulsi, is an aromatic mint-family plant native to the Indian subcontinent. The leaves carry a strong clove-like aroma from their primary essential oil compound, eugenol, and have been used for thousands of years in Ayurvedic medicine. The plant is also considered sacred in Hinduism, where it is grown in temple courtyards and household shrines.
In the Ayurvedic system, Tulsi is classified as a rasayana, a rejuvenative herb taken to support resilience and general well-being. Modern interest sits under the contemporary label of adaptogen. The clinical evidence base is small and mostly drawn from short Indian-published trials; named work includes the Cohen 2014 review of Tulsi in Ayurveda, the Saxena et al. 2012 randomized controlled trial on stress symptoms, and the Jamshidi and Cohen 2017 systematic review of human studies. Holy Basil has no EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) monograph and no permitted EFSA health claim; the entry frames it as an Ayurvedic traditional-use herb, not a clinical treatment.
History
Tulsi has occupied a central place in Indian culture for at least three thousand years. The Sanskrit name Tulsi is often translated as "the incomparable one." In Hindu tradition, the plant is sacred and is associated with the goddess Lakshmi; a Tulsi plant is grown in temple courtyards, in household shrines (Tulsi Vrindavan), and tended daily as part of devotional practice. Leaves are used in puja, in funeral rites, and in Ayurvedic preparations.
Ayurveda classifies Tulsi as a rasayana, a category of herbs used for rejuvenation and to support the body in adapting to stress. Classical Ayurvedic texts including the Charaka Samhita reference Tulsi as a herb for respiratory complaints, fevers, and general resilience. In Western herbal practice the same plant has become known under the contemporary label of adaptogen, an idea drawn from the Soviet-era Russian research tradition and applied to herbs that are thought to support the body under load. Holy Basil is an Indian rasayana, not part of the Austrian Hausmittel tradition.
Mechanism
The leaves contain a characteristic mix of compounds. Eugenol is the dominant essential oil constituent and gives Tulsi its clove-like aroma. Other named compounds include ursolic acid (a triterpenoid), rosmarinic acid (a polyphenol shared with rosemary and many other mint-family herbs), and caryophyllene. These compounds appear repeatedly in laboratory work on the plant.
The proposed adaptogen mechanism comes mostly from animal studies, where Tulsi extracts have been examined for modulation of the hypothalamic-pituitary-adrenal (HPA) axis under experimental stress, and for antioxidant activity in tissues. Direct human mechanistic data is limited. How these laboratory findings translate to the felt experience of taking Tulsi as a tea, capsule, or extract is not fully understood; the clinical mechanistic evidence base is small.
Modern clinical work on Holy Basil sits in a small evidence base. Saxena et al. published a 2012 randomized controlled trial in which adults with mental stress symptoms took a Holy Basil leaf extract over six weeks and reported reductions on standardized stress scales compared to placebo. Jamshidi and Cohen published a 2017 systematic review summarizing the human evidence for Tulsi across cognition, stress, metabolic markers, and immune outcomes, concluding that the available trials are mostly small in scale and mixed in methodology, with promising but not conclusive signals.
The Cohen 2014 review of Tulsi in Ayurveda places the herb in its traditional-use context. Across the body of work, the trials are short, sample sizes are small, and most studies are published in Indian journals. Holy Basil has no EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) monograph and no permitted EFSA health claim. It is best read as a traditional Ayurvedic rasayana with an early and limited modern evidence base, not as a clinical treatment.
Evidence
| Outcome | Class | Grade | Effect | Studies |
|---|---|---|---|---|
| Mental stress symptoms (adaptogen-style use)Saxena et al. 2012 RCT reported reductions on standardized stress scales over six weeks vs placebo using a Tulsi leaf extract. Jamshidi and Cohen 2017 systematic review summarizes a small body of similar trials with promising but not conclusive signals.Adults with self-reported stress symptoms | EmergingEmerging research. Early small trials suggest an effect but await replication. | CEvidence quality grade C. Mixed or limited evidence. Small trials, signals, or traditional use under an EMA HMPC traditional-use monograph. This is an evidence rating, not a product endorsement. | Modest Improvement | |
| Glycemic control / blood sugarSeveral small Indian-published trials and animal studies suggest a hypoglycemic effect. Evidence quality is limited; the Jamshidi and Cohen 2017 review notes the small scale and methodological variation. Practical implication is to monitor blood sugar in people taking diabetes medication.Adults with type 2 diabetes or impaired glucose tolerance | EmergingEmerging research. Early small trials suggest an effect but await replication. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Mixed Effect | |
| Ayurvedic rasayana (rejuvenative) useTulsi is classified as a rasayana in classical Ayurvedic texts (Charaka Samhita and onward) and is used for general resilience and well-being. The Cohen 2014 review of Tulsi in Ayurveda places the herb in this traditional-use context.General adult population in Ayurvedic practice | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | CEvidence quality grade C. Mixed or limited evidence. Small trials, signals, or traditional use under an EMA HMPC traditional-use monograph. This is an evidence rating, not a product endorsement. | Traditional Use | |
| Antioxidant activity (in vitro)Tulsi extracts have shown antioxidant activity in in-vitro assays and animal models, attributed to eugenol, rosmarinic acid, and other polyphenolic compounds. Human clinical translation of these laboratory findings is limited.Laboratory and animal studies | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Lab Signal Only |
Usage
Forms and preparation
Holy Basil is taken as a tea from fresh or dried leaves, as a tincture, as capsules, as a standardized extract, or as dried leaf powder. For a tea, use five to ten fresh leaves or about one teaspoon of dried leaves per cup, cover with hot but not boiling water, and steep for five to ten minutes. The aroma is strong and clove-like; cover the cup while it steeps to keep the essential oils in the brew. For capsules or a standardized extract, follow the dose printed on the package. Most commercial Tulsi capsules deliver between three hundred and six hundred milligrams of leaf or extract per capsule. A spoon of honey or a slice of fresh ginger is a traditional addition to the tea; both are optional.
Dosage
Typical daily intake in the human studies is in the range of three hundred to two thousand milligrams of dried leaf or leaf extract per day, taken in divided doses. The Saxena et al. 2012 trial used a leaf extract at this range over six weeks. As a tea, one to three cups per day is the everyday range in Ayurvedic practice. Build slowly. Start with one cup of tea per day or the lower end of the capsule range for a week or two, and see how you feel before adjusting. Holy Basil has been used over long periods in the Ayurvedic tradition, but the clinical research is short in duration, so a conservative starting dose and an honest self-check are the right pattern.
Safety
Look-alikes
Toxic look-alikes
Sweet Basil (Ocimum basilicum)
Sweet Basil (Ocimum basilicum) is the culinary cousin, visually similar but with a clearly different aroma: anise-like rather than clove-like. The tradition differs too: Mediterranean cuisine versus Ayurvedic medicine. The two are not substitutes for each other, in cooking or in use.
FAQs
What is the difference between Holy Basil and Sweet Basil?
Holy Basil (Ocimum tenuiflorum, Tulsi) and Sweet Basil (Ocimum basilicum) are different species in the same mint family. The aroma differs: Holy Basil is clove-like (from eugenol), Sweet Basil is anise-like (from estragole and linalool). The traditional use also differs: Sweet Basil is a culinary herb in Mediterranean cooking, while Holy Basil is an Ayurvedic medicinal herb classified as a rasayana. They are not substitutes for each other.
What does "adaptogen" mean?
Adaptogen is a contemporary term, drawn from Soviet-era Russian research, used for herbs thought to support the body in adapting to everyday load. It is a descriptive label rather than a regulated medical category; the EU has no permitted health claim for adaptogens. In the case of Holy Basil, the label is applied to the same plant that Ayurveda has long classified as a rasayana, a rejuvenative herb. The modern adaptogen framing and the traditional Ayurvedic rasayana framing point at the same plant from different traditions.
How long can I take Holy Basil?
In Ayurvedic practice Tulsi has been taken over long periods. The clinical research, however, is short: most trials run for six to twelve weeks. A reasonable pattern is to start at the lower end of the dose range, observe how you feel over several weeks, and take occasional breaks. If you are on prescription medication, particularly anticoagulants or diabetes medication, talk to your doctor before extended use.
Which form is most effective: tea, capsule, or extract?
The clinical trials, including Saxena et al. 2012, have mostly used leaf extracts or capsule preparations, so the modest signals in the modern evidence base come from concentrated forms. The traditional Ayurvedic use also includes the tea and fresh-leaf chewing. The honest answer is that the tea is the gentlest, most traditional form, while the capsule and extract are closer to what was tested in the clinical work; neither setting has a definitive head-to-head comparison. Choose the form that fits your routine and start low.
Legal notice: The depiction of historical significance and traditional use is context within our encyclopedia and not a health claim for any product, not a treatment promise, and not a substitute for medical advice. What may be stated on product labels, product pages, or in advertising is governed by the applicable legal requirements.